• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Trastuzumab deruxtecan
    1 Drug classified under this active ingredient


    All the Active Ingredient Drugs

    ENHERTU
    Astra Zeneca
    RX
    partial basket chart
    ENHERTU

    Immunoglobulins. Trastuzumab deruxtecan 20 mg/ml.
    mAb linked to DXd, an exatecan deriv. and a
    topoisomerase I inhibit.
    Vial, 100 mg. Powd. for concentr. for sol. for inf.
     Breast or Lung cancer: 5.4 mg/kg bw once every 21 days
    Gastric cancer: 6.4 mg/kg once every 21 days.
    Do not substitute with trastuzumab or ado-trastuzumab emtansine.
    HER2-Posit. Metast. Breast Cancer ; HER2-Low Metast. Breast Cancer; Unresect. or Metast. HER2-Mutant Non-Small Cell Lung Cancer; Locally Adv. or Metast. Gastric Cancer
    . See Lit
    C/I:
      Hypersens.

    CLOSE